drugset / Trial / NCT02513485

Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa

NCT02513485

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to learn more about the changes that happen in the brain and the body when a person is depressed. This study will determine if the level of inflammation in the body is related to symptoms of depression, how well the person thinks, and how certain brain regions communicate.

Timeline

Start
2015-10-09
Primary completion
2020-02-21
Completion
2020-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbidopa Unknown 50 mg Oral
Comparator Levodopa Small molecule 250 mg Oral